Private company

Fuss Brands Corp.

Fuss Brands Corp. is an American pharmaceutical preparations company based in New York.1

Last updated Oct 20, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersNew York, New York1
  • Incorporated inNV2
  • Business address80 Broad Street, 5Th Floor, New York, Ny 100042
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year20192020
Revenue$03
Operating expenses
Operating income$03
Interest
Income before tax
Income tax$03
Net income$03
Earnings per share
Earnings per share (diluted)
Shares (weighted, basic)
Shares (weighted, diluted)

Compare Fuss Brands Corp. with another company

What it owns

What Fuss Brands Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.4K7 Oct 31, 2024$9.4K7 Oct 31, 2023−84.8%

Properties, in its own words

The Company’s principal business and corporate address is 80 Broad Street New York, New York 10004.

Item 2 of the 10-K filed Feb 11, 2025.8

Leadership

Who has led Fuss Brands Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Li Shaoming2006

Chair

  1. Li Shaoming2006

President

  1. Vincent R. Rinehart2006

Chief financial officer

  1. Yanfei Kong2006
  2. David Dong2010
2010201520202025
Board members and other officers (9)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorIssamar Ginzberg named Jan 18, 202320

Former names

  • China Botanic PharmaceuticalDec 2, 2010 to Jun 14, 20222
  • RENHUANG PHARMACEUTICALS INCMar 21, 2006 to Oct 27, 20102
  • ANZA CAPITAL INCJun 13, 2002 to Aug 15, 20062
  • E-NET FINANCIAL COM CORPMay 5, 2000 to May 21, 20022
  • E-NET COM CORPMar 15, 2000 to Mar 10, 20002
  • E NET FINANCIAL CORPDec 8, 1999 to Jan 26, 20002
  • E NET CORP/NVJul 28, 1999 to Sep 15, 19992
  • E NET CORPMar 19, 1999 to Mar 5, 19992
  • COMTECH CONSOLIDATION GROUP INCMar 5, 1999 to Jan 4, 19992
  • SUARRO COMMUNICATIONS INCJun 23, 1997 to Jun 23, 19972
  • SOLUTIONS INCJul 24, 1996 to Jan 16, 19972

Timeline

  1. Aug 25, 20258-K Change of auditor21
  2. May 8, 20248-K Change of auditor22
  3. Jan 11, 20248-K Executive or director change23
  4. Mar 2, 20238-K Entered a material agreement24
  5. Jan 27, 20238-K Entered a material agreement25
  6. Jan 4, 20238-K Executive or director change26
  7. Dec 5, 20228-K Executive or director change27
  8. Nov 1, 20228-K Entered a material agreement28
  9. Aug 26, 20228-K Bylaws or fiscal year changed; Other events29
  10. Oct 5, 2006New chief executive Li Shaoming becomes CEO9

Filings

36 filings to the SEC since October 2021: 7 annual reports, 14 quarterly reports, 9 major events, 2 private raises, 4 other. The latest 20:

  1. Sep 11, 202510-Q EDGAR
  2. Aug 25, 20258-K EDGAR
  3. Jun 9, 202510-Q EDGAR
  4. Mar 5, 202510-Q EDGAR
  5. Feb 11, 202510-K EDGAR
  6. Jan 28, 2025NT 10-K EDGAR
  7. Sep 6, 202410-Q EDGAR
  8. Jun 27, 202410-Q EDGAR
  9. Jun 13, 2024NT 10-Q EDGAR
  10. May 8, 20248-K EDGAR
  11. Mar 18, 202410-Q EDGAR
  12. Feb 5, 202410-K EDGAR
  13. Jan 29, 2024NT 10-K EDGAR
  14. Jan 11, 20248-K EDGAR
  15. Sep 5, 202310-Q EDGAR
  16. Jun 12, 202310-Q EDGAR
  17. Mar 9, 202310-Q EDGAR
  18. Mar 2, 20238-K EDGAR
  19. Jan 27, 202310-K EDGAR
  20. Jan 27, 20238-K EDGAR

The 36 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jun 4, 2022Raised $78,000 in a private offering of equity Form D: $3 million offered in all Form D

SEC filer profile

How Fuss Brands Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARFuss Brands Corp.1
  • CIK0000926844
  • Employer ID (EIN)87-31434248
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company8
  • Incorporated inNevada8
  • Fiscal year endsOctober 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address80 Broad Street, 5Th Floor, New York, NY 100041
  • Phone917-720-33661
  • Shares outstanding21,453,078 as of Sep 11, 20255
  • Public float$0 as of Apr 30, 20247
  • AuditorOlayinka Oyebola, Lagos, Nigeria PCAOB ID 59688
  • On EDGAR sinceJun 6, 19961
  • Filings428 in all: 8-K (103), 4 (51), 10-Q (45), 3 (26), NT 10-Q (24), 8-K/A (19), 10QSB (16), 10-K (15)1
    All 44 form types

    NT 10-K (14), UPLOAD (12), S-8 (10), 10-K/A (8), 10QSB/A (8), 10KSB (7), CORRESP (6), PRE 14C (6), 10KSB/A (5), DEF 14C (5), 10-Q/A (4), 4/A (4), DEF 14A (4), S-8 POS (4), SC 13G/A (3), 10KSB40 (2), PRER14C (2), RW (2), S-1 (2), S-1/A (2), SC 13D (2), SC 13D/A (2), SC 13G (2), 10KSB40/A (1), 15-15D (1), 25-NSE (1), 8-A12B (1), CERTNYS (1), D (1), D/A (1), DEFA14A (1), DEFR14A (1), DEFR14C (1), DEFS14A (1), NTN 10Q (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-K) Feb 11, 2025
    Quarterly report (10-Q) Sep 11, 2025
    Proxy statement (DEF 14A) Feb 29, 2012
    Latest 8-K (8-K) Aug 25, 2025

Risk factors and legal proceedings

The risks Fuss Brands Corp. names in Item 1A of its 10-K filed Feb 11, 2025: 25 risks under these headings, as written.8

  • Risks Relating to Our Business and Financial Condition
  • We currently have no operations, and investors, therefore, have no basis on which to evaluate the Company’s future prospects.
  • We may face difficulties or delays in our search for a business combination, and we may not have access to sufficient capital to consummate a business combination.
  • If we are not successful in acquiring a new business and generating material revenues, investors will likely lose their investment.
  • If we cannot manage our growth effectively, we may not become profitable.
  • Because we have limited capital, we may need to raise additional capital in the future by issuing debt or equity securities, the terms of which may dilute our current investors and/or reduce or limit their liquidation or other rights.
  • We may be unable to obtain necessary financing if and when required.
  • Because we are still developing our business plan, we do not have any agreement for a business combination.
  • Because we are dependent upon Cheskel Meisels, our Chief Executive Officer and sole director to manage and oversee our Company, the loss of his services could adversely affect our plan and results of operations.
  • Risks Related to a Potential Business Acquisition
  • We may encounter difficulty locating and consummating a business combination, including as a result of the competitive disadvantages we have.
  • We may expend significant time and capital on a prospective business combination that is not ultimately consummated.
The other 15 risks
  • Conflicts of interest may arise between us and our shareholders, directors, or management, which may have a negative impact on our ability to consummate a business combination or favorable terms or generate revenue.
  • We may engage in a business combination that causes tax consequences to us and our shareholders.
  • It is unlikely that our shareholders will be afforded any opportunity to evaluate or approve a business combination.
  • Because our search for a business combination is not presently limited to a particular industry, sector or any specific target businesses, prospective investors will be unable to evaluate the merits or risks of any particular target business’s operations until such time as they are identified and disclosed.
  • Past performance by our management and their affiliates may not be indicative of future performance of an investment in us.
  • We may seek business combination opportunities in industries or sectors that are outside of our management’s area of expertise.
  • We may attempt to complete a business combination with a private target company about which little information is available, and such target entity may not generate revenue as expected or otherwise by compatible with us as expected.
  • Our ability to assess the management of a prospective target business may be limited and, as a result, we may acquire a target business whose management does not have the skills, qualifications, or abilities to enable a seamless transition, which could, in turn, negatively impact our results of operations.
  • Any business we acquire will likely lack diversity of operations or geographical reach, and in such case we will be subject to risks associated with dependence on a single industry or region.
  • Changes in laws or regulations, or a failure to comply with the laws and regulations applicable to us, may adversely affect our business, ability to negotiate and complete a business combination, and results of operations.
  • Risks Related to Our Common Stock
  • Due to factors beyond our control, our stock price may be volatile.
  • Because trading in our Common Stock is so limited, investors who purchase our Common Stock may depress the market if they sell Common Stock.
  • The market price of our Common Stock may decline if a substantial number of shares of our Common Stock are sold at once or in large blocks.
  • Future issuance of our Common Stock could dilute the interests of our existing shareholders, particularly in connection with an acquisition and any resulting financing.
  • Due to recent changes to Rule 15c2-11 under the Securities Exchange Act of 1934, our Common Stock may become subject to limitations or reductions on stock price, liquidity, or volume.

Legal proceedings

We are not currently involved in any legal proceedings and we are not aware of any pending or potential legal actions.

The opening of Item 3, Legal Proceedings.8

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29